Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelvin MedicalKVMD Cash Flow from Financing is $0.09 Mil as of Mar. 2018.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2018,
Kelvin Medical paid$0.00 Mil more to buy back shares than it received from issuing new shares.
It spent$0.01 Mil paying down its debt.
It paid$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received$0.00 Mil from paying cash dividends to shareholders.
It received$0.00 Mil on other financial activities.
In all, Kelvin Medicalspent$0.01 Mil on financial activities for the
three
months ended in Mar. 2018.
Kelvin Medical (OTCPK:KVMD) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Kelvin Medical's issuance of stock for the
three
months ended in Mar. 2018 was $0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Kelvin Medical's repurchase of stock for the
three
months ended in Mar. 2018 was $0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Kelvin Medical's net issuance of debt for the
three
months ended in Mar. 2018 was $-0.01 Mil.
Kelvin Medical spent$0.01 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Kelvin Medical's net issuance of preferred for the
three
months ended in Mar. 2018 was $0.00 Mil.
Kelvin Medical paid$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Kelvin Medical's cash flow for dividends for the
three
months ended in Mar. 2018 was $0.00 Mil.
Kelvin Medical received$0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Kelvin Medical's other financing for the
three
months ended in Mar. 2018 was $0.00 Mil.
Kelvin Medical received$0.00 Mil on other financial activities.
Kelvin Medical Cash Flow from Financing Related Terms
Kelvin Medical Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Kelvin Medical's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelvin Medical Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Kelvin Medical's Cash from Financing for the fiscal year that ended in Jun. 2017 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $0.09 Mil mean?
Kelvin Medical (KVMD) has a Cash Flow from Financing of $0.09 Mil as of Mar. 2018. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Kelvin Medical and its competitors.
Is Kelvin Medical's Cash Flow from Financing too high?
Kelvin Medical's current Cash Flow from Financing is $0.09 Mil.
How does Kelvin Medical's Cash Flow from Financing compare to XTNT and ACRX?
Kelvin Medical's Cash Flow from Financing of $0.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Medical Devices & Instruments company?
A good Cash Flow from Financing depends on the Medical Devices & Instruments industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Kelvin Medical and its competitors. Kelvin Medical's current Cash Flow from Financing is $0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelvin Medical stock overvalued right now?
Kelvin Medical (KVMD) has a current Cash Flow from Financing of $0.09 Mil. The current Cash Flow from Financing is $0.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Kelvin Medical (KVMD), the current Cash Flow from Financing is $0.09 Mil as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kelvin Medical Inc is a consumer medical device company. It is engaged in the development, production, and sale of medical devices. The company intends to serve the healthcare services companies who specialize in the distribution of medical products, pharmacies, representatives and sporting goods stores. The company has developed the Therm-N-Ice is a wearable consumer medical device.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KVMD has been successfully added to your 
